间歇性与连续性肠内喂养对危重症肌肉消耗的影响:一项2期临床试验
该2期单盲随机对照试验纳入121例多器官衰竭的机械通气成人患者,随机分为间歇性肠内喂养组(每24小时6次、每次4小时,n=62)与标准连续性肠内喂养组(n=59)。主要终点为超声测定的10天股直肌横截面积丢失,两组相似(-1.1% [95%CI, -6.1% to -4.0%];P=.676)。间歇喂养组更多患者达到80%以上目标蛋白(OR 1.52 [1.16-1.99];P<.001)和能量(OR 1.59 [1.21-2.08];P=.001),但10天干预期间血糖变异系数更高(间歇组17.84 [18.6-20.4] vs 连续组12.98 [14.0-15.7];P<.001),低血糖报告天数和胰岛素使用天数两组相似。作者认为间歇喂养在早期危重症中可行且安全,但未显示能保留肌肉量。
要点
- 主要终点:10天股直肌横截面积丢失两组相似(-1.1% [95%CI, -6.1% to -4.0%];P=.676),间歇喂养未显示保留肌肉量。
- 间歇喂养组更多患者达到80%以上目标蛋白(OR 1.52 [1.16-1.99];P<.001)和能量(OR 1.59 [1.21-2.08];P=.001)。
- 10天干预期间血糖变异系数间歇组17.84 [18.6-20.4] vs 连续组12.98 [14.0-15.7](P<.001),但低血糖报告天数和胰岛素使用天数两组相似。
- 安全性、胃不耐受、躯体功能里程碑和出院去向两组无差异。
- 作者结论:间歇喂养在早期危重症中可行且安全,但未显示能保留肌肉量。
适用人群与场景
- 机械通气的成人多器官衰竭患者,在获得前瞻性知情同意(consulttee assent)后招募。
处置流程与药物剂量
- 间歇性肠内喂养:每24小时6次、每次4小时的喂养(干预组,n=62)。
- 连续性肠内喂养:标准持续肠内喂养(对照组,n=59)。
研究设计与关键结果
- 2期干预性单盲随机对照试验,纳入121例机械通气成人多器官衰竭患者,随机分为间歇性肠内喂养组(n=62)与连续性肠内喂养组(n=59)。
- 主要终点10天股直肌横截面积丢失两组相似:-1.1% [95%CI, -6.1% to -4.0%];P=.676。
- 间歇喂养组更多患者接受80%以上目标蛋白(OR 1.52 [1.16-1.99];P<.001)和能量(OR 1.59 [1.21-2.08];P=.001)。
- 血浆支链氨基酸浓度喂养前后两组相似:试验第1天71 μM [44-98 μM](P=.547),第10天239 μM [33-444 μM](P=.178)。
- 10天干预期间血糖变异系数间歇喂养组17.84 [18.6-20.4] vs 连续喂养组12.98 [14.0-15.7](P<.001);低血糖报告天数和胰岛素使用天数两组相似。
- 安全性特征、胃不耐受、躯体功能里程碑和出院去向两组无差异。
证据类型、等级与局限
- 证据类型:2期干预性单盲随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 间歇性肠内喂养在早期危重症中可行且安全,但未显示能保留肌肉量(作者结论)。
- 间歇喂养可能更多达到营养目标,但血糖变异系数更高,需注意血糖监测。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute skeletal muscle wasting in critical illness is associated with excess morbidity and mortality. Continuous feeding may suppress muscle protein synthesis as a result of the muscle-full effect, unlike intermittent feeding, which may ameliorate it.
RESEARCH QUESTION: Does intermittent enteral feed decrease muscle wasting compared with continuous feed in critically ill patients?
STUDY DESIGN AND METHODS: In a phase 2 interventional single-blinded randomized controlled trial, 121 mechanically ventilated adult patients with multiorgan failure were recruited following prospective informed consultee assent. They were randomized to the intervention group (intermittent enteral feeding from six 4-hourly feeds per 24 h, n = 62) or control group (standard continuous enteral feeding, n = 59). The primary outcome was 10-day loss of rectus femoris muscle cross-sectional area determined by ultrasound. Secondary outcomes included nutritional target achievements, plasma amino acid concentrations, glycemic control, and physical function milestones.
RESULTS: Muscle loss was similar between arms (-1.1% [95% CI, -6.1% to -4.0%]; P = .676). More intermittently fed patients received 80% or more of target protein (OR, 1.52 [1.16-1.99]; P < .001) and energy (OR, 1.59 [1.21-2.08]; P = .001). Plasma branched-chain amino acid concentrations before and after feeds were similar between arms on trial day 1 (71 μM [44-98 μM]; P = .547) and trial day 10 (239 μM [33-444 μM]; P = .178). During the 10-day intervention period the coefficient of variation for glucose concentrations was higher with intermittent feed (17.84 [18.6-20.4]) vs continuous feed (12.98 [14.0-15.7]; P < .001). However, days with reported hypoglycemia and insulin usage were similar in both groups. Safety profiles, gastric intolerance, physical function milestones, and discharge destinations did not differ between groups.
INTERPRETATION: Intermittent feeding in early critical illness is not shown to preserve muscle mass in this trial despite resulting in a greater achievement of nutritional targets than continuous feeding. However, it is feasible and safe.
TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT02358512; URL: www.clinicaltrials.gov.
参考来源
- McNelly AS, Bear DE, Connolly BA, et al. Effect of Intermittent or Continuous Feed on Muscle Wasting in Critical Illness: A Phase 2 Clinical Trial. Chest. 2020. PMID: 32247714. doi:10.1016/j.chest.2020.03.045
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。